Search

everythinglearnresearchcommunity

for

Search:↓

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Quercetin effectively treated and prevented hair loss in mice.

Platelet-rich plasma therapy improves oral lichen planus symptoms with few side effects.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Human skin has less GDNF and its receptor with age.

Chirality influences the structure, strength, and biological uses of peptide-based hydrogels.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

New treatments are needed for non-scarring alopecia due to current limitations.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Gut bacteria may influence hair loss in alopecia areata.